norfloxacin has been researched along with Fatigue Syndrome, Chronic in 1 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Fatigue Syndrome, Chronic: A syndrome characterized by persistent or recurrent fatigue, diffuse musculoskeletal pain, sleep disturbances, and subjective cognitive impairment of 6 months duration or longer. Symptoms are not caused by ongoing exertion; are not relieved by rest; and result in a substantial reduction of previous levels of occupational, educational, social, or personal activities. Minor alterations of immune, neuroendocrine, and autonomic function may be associated with this syndrome. There is also considerable overlap between this condition and FIBROMYALGIA. (From Semin Neurol 1998;18(2):237-42; Ann Intern Med 1994 Dec 15;121(12): 953-9)
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 77-year-old male who had suffered from an upper respiratory infection and had been given Norfloxacin (NFLX) on May 2, 1990, developed generalized erythema which did not subside with prednisolone." | 7.68 | [Norfloxacin-induced infectious mononucleosis (IM)-like syndrome with Stevens-Johnson syndrome]. ( Kubo-Shimasaki, A; Tatsumi, E; Yamaguchi, N; Yoneda, N; Yoshimoto, K, 1992) |
| "A 77-year-old male who had suffered from an upper respiratory infection and had been given Norfloxacin (NFLX) on May 2, 1990, developed generalized erythema which did not subside with prednisolone." | 3.68 | [Norfloxacin-induced infectious mononucleosis (IM)-like syndrome with Stevens-Johnson syndrome]. ( Kubo-Shimasaki, A; Tatsumi, E; Yamaguchi, N; Yoneda, N; Yoshimoto, K, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kubo-Shimasaki, A | 1 |
| Yoshimoto, K | 1 |
| Tatsumi, E | 1 |
| Yoneda, N | 1 |
| Yamaguchi, N | 1 |
1 other study available for norfloxacin and Fatigue Syndrome, Chronic
| Article | Year |
|---|---|
[Norfloxacin-induced infectious mononucleosis (IM)-like syndrome with Stevens-Johnson syndrome].
Topics: Aged; Drug Hypersensitivity; Erythema; Fatigue Syndrome, Chronic; Humans; Male; Norfloxacin; Stevens | 1992 |